CPT1A and chronic kidney disease: A study has shown that advanced CKD contributes to the up-regulation of SREBP-1/ChREBP-mediated DNL-associated enzymes and the depression of CPT-1-mediated FAO activity in the liver, accompanied by hepatic fat accumulation [124].